机器学习与自然语言处理预测HR+/HER2-晚期乳腺癌一线治疗早期进展
本研究利用真实世界HR+/HER2-晚期乳腺癌患者电子健康记录,开发预测一线治疗早期和晚期进展的模型。采用手动提取特征的传统机器学习与自由文本临床笔记的自然语言处理(NLP)两种方法。结果显示NLP模型预测早期进展的AUC为0.758,略优于手动提取数据的0.734;预测长缓解者的AUC为0.752,也优于手动数据的0.669。
要点
- NLP模型预测早期进展AUC 0.758,略优于手动特征模型的0.734。
- NLP模型预测长缓解者AUC 0.752,优于手动特征模型的0.669。
- 610例中77.5%出现一线进展,20.6%在6个月内早期进展。
核心结论
- 基于NLP的机器学习模型在预测HR+/HER2-晚期乳腺癌一线治疗早期和晚期进展方面略优于基于手动提取数据的模型。
研究设计与样本
- 利用真实世界HR+/HER2-晚期乳腺癌患者电子健康记录数据开发预测模型,共纳入610例患者。
- 采用两种机器学习方法:基于手动提取特征的数据集和基于自由文本临床笔记的NLP方法。
主要发现
- 610例患者中473例(77.5%)出现一线治疗进展,其中126例(20.6%)在6个月内进展。
- 152例患者(24.9%)在一线治疗开始后28个月内未出现疾病进展。
- 手动提取数据预测早期进展的最佳模型AUC为0.734(95% CI 0.687-0.782)。
- NLP自由文本处理预测早期进展的最佳模型AUC为0.758(95% CI 0.714-0.800)。
- 手动提取数据预测长缓解者的最佳模型AUC为0.669(95% CI 0.608-0.730);NLP最佳模型AUC为0.752(95% CI 0.705-0.799)。
临床怎么用
- NLP-based机器学习模型可利用真实世界自由文本临床笔记辅助预测HR+/HER2-晚期乳腺癌一线治疗早期进展和长缓解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CDK4/6 inhibitors plus endocrine therapies are the current standard of care in the first-line treatment of HR+/HER2-negative metastatic breast cancer, but there are no well-established clinical or molecular predictive factors for patient response. In the era of personalised oncology, new approaches for developing predictive models of response are needed. MATERIALS AND METHODS: Data derived from the electronic health records (EHRs) of real-world patients with HR+/HER2-negative advanced breast cancer were used to develop predictive models for early and late progression to first-line treatment. Two machine learning approaches were used: a classic approach using a data set of manually extracted features from reviewed (EHR) patients, and a second approach using natural language processing (NLP) of free-text clinical notes recorded during medical visits. RESULTS: Of the 610 patients included, there were 473 (77.5%) progressions to first-line treatment, of which 126 (20.6%) occurred within the first 6 months. There were 152 patients (24.9%) who showed no disease progression before 28 months from the onset of first-line treatment. The best predictive model for early progression using the manually extracted dataset achieved an area under the curve (AUC) of 0.734 (95% CI 0.687-0.782). Using the NLP free-text processing approach, the best model obtained an AUC of 0.758 (95% CI 0.714-0.800). The best model to predict long responders using manually extracted data obtained an AUC of 0.669 (95% CI 0.608-0.730). With NLP free-text processing, the best model attained an AUC of 0.752 (95% CI 0.705-0.799). CONCLUSIONS: Using machine learning methods, we developed predictive models for early and late progression to first-line treatment of HR+/HER2-negative metastatic breast cancer, also finding that NLP-based machine learning models are slightly better than predictive models based on manually obtained data.
引用
- Ribelles N, Jerez JM, Rodriguez-Brazzarola P, et al. Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients. Eur J Cancer. 2020. PMID: 33373867. doi:10.1016/j.ejca.2020.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。